[Treatment of myasthenia gravis in children].
D000293:Adolescent; D000367:Age Factors; D002648:Child; D005260:Female; D006801:Humans; D009157:Myasthenia Gravis / Q000188:drug therapy / Q000628:therapy*; D009388:Neostigmine / Q000627:therapeutic use; D013148:Spironolactone / Q000627:therapeutic use; D013934:Thymectomy
D013148:Spironolactone; D009388:Neostigmine
W sprawie leczenia myasthenia gravis u dzieci.